Prevalence of adverse drug events in ambulatory care: A systematic review;La prevalencia de eventos adversos de fármacos en el cuidado ambulatorio: Un repaso sistemático

Annals of Pharmacotherapy

Volumn 45, Issue 7-8, 2011, Pages 977-989

  Taché, Stephanie V ^a   Sönnichsen, Andreas ^a   Ashcroft, Darren M ^b  

^a PARACELSUS MEDICAL UNIVERSITY   (Austria)

^b UNIVERSITY OF MANCHESTER   (United Kingdom)

Author keywords

Adverse drug events; Ambulatory care; Preventable adverse drug events; Primary care

Indexed keywords

ANALGESIC AGENT; ANTIDIABETIC AGENT; ANTIEMETIC AGENT; ANTIINFECTIVE AGENT; ANTINEOPLASTIC AGENT; CARDIOVASCULAR AGENT; CENTRAL NERVOUS SYSTEM AGENTS; GASTROINTESTINAL AGENT;

AGE DISTRIBUTION; AMBULATORY CARE; ARTICLE; DATA EXTRACTION; DRUG SAFETY; EMBASE; GERIATRIC PATIENT; HOSPITAL ADMISSION; HUMAN; MEDICAL LITERATURE; MEDLINE; PRIMARY MEDICAL CARE; PRIORITY JOURNAL; PUBLICATION; SYSTEMATIC REVIEW; UNSPECIFIED SIDE EFFECT;

ADULT; AGE FACTORS; AGED; AMBULATORY CARE; CHILD; DRUG TOXICITY; HUMANS; MEDICATION ERRORS; PREVALENCE; RISK FACTORS;

EID: 79960791739     PISSN: 10600280     EISSN: None     Source Type: Journal    
DOI: 10.1345/aph.1P627     Document Type: Article

References (75)

1. Avery A, Sheikh A, Hurwitz B, et al. Safer medicines management in primary care. Br J Gen Pract 2002;52:S17-S22.
2. Jha AK, Kuperman GJ, Teich JM, et al. Identifying adverse drug events. J Am Med Inform Assoc 1998;5:305-14.
3. Gandhi TK, Weingart SN, Borus J, et al. Adverse drug events in ambulatory care. N Engl J Med 2003;348:1556-64. DOI 10.1056/NEJMsa020703
4. NHS Information Centre. Hospital prescribing, 2008, England. London: The Health and Social Care Information Centre, Prescribing Support and Primary Care Services, 2009 Oct 29.
5. Cals J, Butler CC, Hopstaken RM, Hood K, Dinant GJ. Effect of point of care testing for C reactive protein and training in communication skills on antibiotic use in lower respiratory tract infections: cluster randomised trial. BMJ 2009;338:b1374. DOI 10.1136/bmj.b1374
6. Patterns of medication use in the United States, 2006: a report from the Slone Survey, Boston, MA: Slone Epidemiology Center, 2006.
7. Cherry D, Woodwell DA, Rechsteiner EA. National ambulatory care survey: 2005 summary. Adv Data 2007;387:1-39.
8. Bourgeois F, Shannon MW, Valim C, Mandl KD. Adverse drug events in the outpatient setting: an 11-year national analysis. Pharmacoepidemiol Drug Saf 2010;19:901-10.
9. NHS Information Centre. Prescriptions dispensed in the community: statistics for 1998 to 2008. London: The Health and Social Care Information Centre. Prescribing Support Unit, July 29, 2009.
10. Thomsen LA, Winterstein AG, Søndergaard B, Haugbølle LS, Melander A. Systematic review of the incidence and characteristics of preventable adverse drug events in ambulatory care. Ann Pharmacother 2007;41: 1411-26. DOI 10.1345/aph.1H658
11. Al-Olah Y, Al Thiab K. Admissions through the emergency department due to drug-related problems. Ann Saudi Med 2008;28:426-9. DOI 10.4103/0256-4947.51671
12. Ashcroft D, Kongkaew C, Williams S, Metcalfe D, Mandal J, Noyce P. Prevalence, clinical profile and preventability of drug-related hospital admissions: prospective observational study Pharmacoepidemiol. Drug Saf 2009;18:S121.
13. Capuano A, Irpino A, Gallo M, et al. Regional surveillance of emergency-department visits for outpatient adverse drug events. Eur J Clin Pharmacol 2009;65:721-8. DOI 10.1007/s00228-009-0641-8
14. Cohen AL, Budnitz DS, Weidenbach KN, et al. National surveillance of emergency department visits for outpatient adverse drug events in children and adolescents. J Pediatr 2008;152:416-21.e2.
15. Ganjavi H, Herrmann N, Rochon PA, et al. Adverse drug events in cog-nitively impaired elderly patients. Dement Geriatr Cogn Disord 2007; 23:395-400.
16. Kaushal R, Goldmann DA, Keohane CA, et al. Adverse drug events in pediatric outpatients. Ambul Pediatr 2007;7:383-9.
17. Queneau P, Bannwarth B, Carpentier F, et al. Emergency department visits caused by adverse drug events: results of a French survey. Drug Saf 2007;30:81-8.
18. Sikdar KC, Alaghehbandan R, MacDonald D, et al. Adverse drug events in adult patients leading to emergency department visits. Ann Pharma-cother 2010;44:641-9. DOI 10.1345/aph.1M416
19. Sikdar KC, Alaghehbandan R, MacDonald D, Barrett B, Collins KD, Gadag V. Adverse drug events among children presenting to a hospital emergency department in Newfoundland and Labrador, Canada. Phar-macoepidemiol Drug Saf 2010;19:132-40. DOI 10.1002/pds.1900
20. Sotoca Momblona J, Canivell Fusté S, Alemany Vilches L, Sisó Almirall A, Codina Jané C, Ribas SJ. Drug related problems and hospital admissions. Aten Primaria 2009;41:141-6. DOI 10.1016/j.aprim.2008.07.002
21. Bates DW, Cullen DJ, Laird N, et al. Incidence of adverse drug events and potential adverse drug events: implications for prevention. JAMA 1995;274:29-34. DOI 10.1001/jama.1995.03530010043033
22. Definition of medication errors. 2010. www.nccmerp.org/aboutMedErrors.html (accessed 2010 Jan 12).
23. Dennehy C, Kishi D, Louie C. Drug-related illness in emergency department patients. Am J Health Syst Pharm 1996;53:1422-6.
24. Hafner JW, Belknap SM, Squillante MD, Bucheit KA. Adverse drug events in emergency department patients. Ann Emerg Med 2002;39:258-67. DOI 10.1067/mem.2002.121401
25. Prince B, Goetz CM, Rihn TL, Olsky M. Drug-related emergency department visits and hospital admissions. Am J Hosp Pharm 1992;49: 1696-700.
26. Climente C, Quintana V, Martínez G, et al. Prevalencia y características de la morbilidad relacionada con los medicamentos como causa de ingre-so hospitalario. Aten Farm 2001;3:9-22.
27. Easton K, Parsons BJ, Starr M, Brien JE. The incidence of drug-related problems as a cause of hospital admissions in children. Med J Aust 1998; 169:356-9.
28. Easton-Carter KL, Chapman CB, Brien JE. Emergency department attendances associated with drug-related problems in paediatrics. J Paediatr Child Health 2003;39:124-9. DOI 10.1046/j.1440-1754.2003.00103.x
29. Güemes Artiles M, Sanz Alvarez E, García Sánchez-Colomer M. Reac-ciones adversas y problemas relacionados con medicamentos en un ser-vicio de urgencia. Revista Española de Salud Pública 1999;73:507-14.
30. Capuano A, Motola G, Russo F, et al. Adverse drug events in two emergency departments in Naples, Italy: an observational study. Pharmacol Res 2004;50:631-6. DOI 10.1016/j.phrs.2004.05.008
31. Dartnell J, Anderson RP, Chohan V, et al. Hospitalisation for adverse events related to drug therapy: incidence, avoidability and costs. Med J Aust 1996;164:659-62.
32. Ives T, Bentz EJ, Gwyther RE. Drug-related admissions to a family medicine inpatient service. Arch Intern Med 1987;147:1117-20.
33. Zed P, Abu-Laban R, Balen R, et al. Incidence, severity and preventabili-ty of medication-related visits to the emergency department: a prospective study. CMAJ 2008;178:1563-9. DOI 10.1503/cmaj.071594
34. Grymonpre R. Drug associated hospital admission in older patients. J Am Geriatr Soc 1988;36:1092-8.
35. Gouet D. [Iatrogenic disease caused by medication as a cause of admission in an internal medicine ward. Results of a prospective study over 6 months.] Ann Med Interne (Paris) 1987;138:148-9.
36. Lakshmanan MC, Hershey CO, Breslau D. Hospital admissions caused by iatrogenic disease. Arch Intern Med 1986;146:1931-4. DOI 10.1001/archinte.1986.00360220075016
37. Edwards IR, Aronson JK. Adverse drug reactions: definitions, diagnosis, and management. Lancet 2000;356:1255-9.
38. McDonnell PJ, Jacobs MR. Hospital admissions resulting from preventable adverse drug reactions. Ann Pharmacother 2002;36:1331-6. DOI 10.1345/aph.1A333
39. Hallas J, Worm J, Beck-Nielsen J, et al. Drug related events and drug utilization in patients admitted to a geriatric hospital department. Dan Med Bull 1991;38:417-20.
40. Hallas J, Davidsen O, Grodum E, Damsbo N, Gram LF. Drug-related illness as a cause of admission to a department of respiratory medicine. Respiration 1992;59:30-4.
41. Hallas J, Gram LF, Grodum E, et al. Drug related admissions to medical wards: a population based survey. Br J Clin Pharmacol 1992;33:61-8.
42. Hallas J, Haghfelt T, Gram LF, Grodum E, Damsbo N. Drug related admissions to a cardiology department: frequency and avoidability. J Intern Med 1990;228:379-84. DOI 10.1111/j.1365-2796.1990.tb00249.x
43. Hallas J, Harvald B, Gram LF, et al. Drug related hospital admissions: the role of definitions and intensity of data collection, and the possibility of prevention. J Intern Med 1990;228:83-90. DOI 10.1111/j.1365-2796.1990.tb00199.x
44. Hallas J, Jensen KB, Grodum E, Damsbo N, Gram LF. Drug-related admissions to a department of medical gastroenterology: the role of self-medicated and prescribed drugs. Scand J Gastroenterol 1991;26:174-80. DOI 10.3109/00365529109025028
45. Atkin PA, Finnegàn TP, Ogle SJ, Talmont DM, Shenfield GM. Prevalence of drug related admissions to a hospital geriatric service. Australasian J Ageing 1994;13:17-21.
46. Ghose K. Hospital bed occupancy due to drug-related problems. J R Soc Med 1980;73:853-6.
47. Jönsson AK, Hakkarainen KM, Spigset O, Druid H, Hiselius A, Hägg S. Preventable drug related mortality in a Swedish population. Pharma-coepidemiol Drug Saf 2010;19:211-5. DOI 10.1002/pds.1890
48. Lindley CM, Tully MP, Paramsothy V, Tallis RC. Inappropriate medication is a major cause of adverse drug reactions in elderly patients. Age Ageing 1992;21:294-300. DOI 10.1093/ageing/21.4.294
49. Schneeweiss S. Admissions caused by ADEs to internal medicine and emergency departments in hospitals: a longitudinal population based study. Eur J Clin Pharmacol 2001;58:285-91.
50. Schuler J, Dückelmann C, Beindl W, Prinz E, Michalski T, Pichler M. Polypharmacy and inappropriate prescribing in elderly internal-medicine patients in Austria. Wiener Klinische Wochenschrift 2008;120:733-41. DOI 10.1007/s00508-008-1089-z
51. Zhan C, Arispe I, Kelley E, et al. Ambulatory care visits for treating adverse drug effects in the United States, 1995-2001. Jt Comm J Qual Patient Saf 2005;31:372-8.
52. Raschetti R, Morgutti M, Menniti-Ippolito F, et al. Suspected adverse drug events requiring emergency department visits or hospital admissions. Eur J Clin Pharmacol 1999;54:959-63. DOI 10.1007/s002280050582
53. Gandhi TK, Burstin HR, Cook EF, et al. Drug complications in outpa tients. J Gen Intern Med 2000;15:149-54. DOI 10.1046/j.1525-1497.2000.04199.x
54. Gurwitz JH, Field TS, Harrold LR, et al. Incidence and preventability of adverse drug events among older persons in the ambulatory setting. JAMA 2003;289:1107-16. DOI 10.1001/jama.289.9.1107
55. Hanlon J, Schmader KE, Koronkowski MJ, et al. Adverse drug events in high risk older outpatients. J Am Geriatr Soc 1997;45:945-8.
56. Buajordet I, Wesenberg F, Brørs O, Langslet A. Adverse drug events in children during hospitalization and after discharge in a Norwegian university hospital. Acta Pædiatrica 2002;91:88-94. DOI 10.1111/j.1651-2227.2002.tb01647.x
57. Budnitz D, Pollock DA, Mendelsohn AB, Weidenbach KN, McDonald AK, Annest JL. Emergency department visits for outpatient adverse drug events: demonstration for a national surveillance system. Ann Emerg Med 2005;45:197-206.
58. Budnitz DS, Pollock DA, Weidenbach KN, Mendelsohn AB, Schroeder TJ, Annest JL. National surveillance of emergency department visits for outpatient adverse drug events. JAMA 2006;296:1858-66. DOI 10.1001/jama.296.15.1858
59. Cannon J, Hughes CM. An assessment of the incidence and factors leading to drug-related hospital admissions in the elderly. Eur Hosp Pharm 1997;3:14-8.
60. Caranasos G, Stewart RB, Cluff LE. Drug-induced illness leading to hos-pitalization. JAMA 1974;228:713-7.
61. Chan M, Nicklason F, Vial JH. Adverse drug events as a cause of hospital admission in the elderly. Intern Med J 2001;31:199-205. DOI 10.1046/j.1445-5994.2001.00044.x
62. Forster A, Asmis TR, Clark HD, et al. Ottawa hospital patient safety study: incidence and timing of adverse events in patients admitted to a Canadian teaching hospital. CMAJ 2004;170:1235-40.
63. Forster AJ, Murff HJ, Peterson JF, Gandhi TK, Bates DW. The incidence and severity of adverse events affecting patients after discharge from the hospital. Ann Intern Med 2003;138:161-7.
64. Jha AK, Kuperman GJ, Rittenberg E, Teich JM, Bates DW. Identifying hospital admissions due to adverse drug events using a computer-based monitor. Pharmacoepidemiol Drug Saf 2001;10:113-9. DOI 10.1002/pds.568
65. Otero López MJ, Alonso Hernández P, Maderuelo Fernández JA, Ceru-elo Bermejo J, Domínguez-Gil Hurlé A, Sánchez Rodríguez A. [Prevalence and factors associated with preventable adverse drug events leading to hospital admission] (Spanish). Farm Hosp 2006;30:161-70.
66. Otero López MJ, Bajo Bajo A, Maderuelo Fernández JA, Domínguez-Gil Hurlé A. [Preventable adverse drug effects at an emergency department] (Spanish). Rev Clin Esp 1999;199:796-805.
67. Queneau P. Adverse drug effects: a prospective study by Apnet performed in seven emergency care units in France: propositions for preventive measures. Ann Pharm Fr 2005;63:131-42.
68. Senst B, Achusim LE, Genest R P, et al. Practical approach to determining costs and frequency of adverse drug events in a health care network. Am J Health Syst Pharm 2001;58:1126-32.
69. Smith K, McAdams J, Frenia M, Todd M. Drug-related problems in emergency department patients. Am J Health Syst Pharm 1997;54:295-8.
70. Trifirò G, Calogero G, Ippolito FM, et al. Adverse drug events in emergency department population: a prospective Italian study. Pharmacoepi-demiol Drug Saf 2005;14:333-40. DOI 10.1002/pds.1074
71. Reason J. Human error. New York: Cambridge University Press, 1990.
72. Howard RL, Avery AJ, Slavenburg S, et al. Which drugs cause preventable admissions to hospital? A systematic review. Br J Clin Pharmacol 2007;63:136-47. DOI 10.1111/j.1365-2125.2006.02698.x
73. Bourgeois FT, Mandl KD, Valim C, Shannon MW. Pediatric adverse drug events in the outpatient setting: an 11-year national analysis. Pediatrics 2009;124:e744-e750. DOI 1542/peds.2008-3505
74. Howard R, Avery A, Bissell P. Causes of preventable drug-related hospital admissions: a qualitative study. Qual Saf Health Care 2008;17:109-16. DOI 10.1136/qshc.2007.022681
75. Leape LL, Bates DW, Cullen DJ, et al. Systems analysis of adverse drug events. JAMA 1995;274:35-43. DOI 10.1001/jama.1995.03530010049034